Your browser doesn't support javascript.
loading
Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registers.
Nielsen, Stine; Hansen, Janne Fuglsang; Hay, Gordon; Cowan, Susan; Jepsen, Peter; Omland, Lars Haukali; Krarup, Henrik Bygum; Søholm, Jacob; Lazarus, Jeffrey V; Weis, Nina; Øvrehus, Anne; Christensen, Peer Brehm.
  • Nielsen S; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Hansen JF; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Hay G; Centre for Public Health, Liverpool John Moores University, Liverpool, United Kingdom.
  • Cowan S; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Jepsen P; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Omland LH; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Krarup HB; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Søholm J; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.
  • Lazarus JV; Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark.
  • Weis N; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Øvrehus A; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Christensen PB; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
PLoS One ; 15(9): e0238203, 2020.
Article en En | MEDLINE | ID: mdl-32881877
BACKGROUND: Chronic hepatitis C (CHC) can be eliminated as a public health threat by meeting the WHO targets: 90% of patients diagnosed and 80% treated by 2030. To achieve and monitor progress towards elimination, an updated estimate of the size of the CHC population is needed, but Denmark has no complete national CHC register. By combining existing registers in 2007, we estimated the population living with CHC to be 16,888 (0.38% of the adult population). AIM: To estimate the population living with diagnosed and undiagnosed CHC in Denmark on 31 December 2016. Among additional aims were to estimate the proportion of patients attending specialised clinical care. METHODS: People with diagnosed CHC were identified from four national registers. The total diagnosed population was estimated by capture-recapture analysis. The undiagnosed population was estimated by comparing the register data with data from two cross-sectional surveys. RESULTS: The population living with diagnosed CHC in Denmark was 7,581 persons (95%CI: 7,416-12,661) of which 6,116 (81%) were identified in the four registers. The estimated undiagnosed fraction was 24%, so the total CHC infected population was 9,975 corresponding to 0.21% of the adult population (95%CI: 9,758-16,659; 0.21%-0.36%). Only 48% of diagnosed patients had received specialised clinical care. CONCLUSION: CHC prevalence in Denmark is declining and 76% of patients have been diagnosed. Linking diagnosed patients to care and increasing efforts to test people with former or current drug use will be necessary to achieve CHC elimination.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis C Crónica Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis C Crónica Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article